Moreover, considering the crucial stakes of EGFR status in the management of NSCLC patients at diagnosis and during disease monitoring, orthogonal assays should be systematically performed in cases of low DNA amounts and EGFR WT results. Here, EGFR is linked to non-small cell lung carcinoma.